Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

PharmaCyte Biotech (PMCB) Times Interest Earned (2016 - 2022)

PharmaCyte Biotech (PMCB) has disclosed Times Interest Earned for 11 consecutive years, with -$430.26 as the latest value for Q3 2022.

  • Quarterly Times Interest Earned rose 32.73% to -$430.26 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was -$1652.7 through Apr 2023, up 38.21% year-over-year, with the annual reading at -$8628.7 for FY2022, 182.94% down from the prior year.
  • Times Interest Earned for Q3 2022 was -$430.26 at PharmaCyte Biotech, up from -$23924.8 in the prior quarter.
  • The five-year high for Times Interest Earned was -$430.26 in Q3 2022, with the low at -$23924.8 in Q4 2021.
  • Average Times Interest Earned over 3 years is -$4766.4, with a median of -$1655.4 recorded in 2020.
  • Peak annual rise in Times Interest Earned hit 71.85% in 2021, while the deepest fall reached 1605.83% in 2021.
  • Over 3 years, Times Interest Earned stood at -$1402.5 in 2020, then plummeted by 1605.83% to -$23924.8 in 2021, then soared by 98.2% to -$430.26 in 2022.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$430.26, -$23924.8, and -$639.59 for Q3 2022, Q4 2021, and Q3 2021 respectively.